Dupilumab improves signs, symptoms, and quality of life in adolescents with moderate to severe atopic dermatitis

被引：0

作者：

Eichenfield, Lawrence F.

Silverberg, Jonathan I. ^{[1
]}

Gadkari, Abhijit ^{[2
]}

Guillemin, Isabelle ^{[3
]}

Chen, Zhen ^{[3
]}

Bansal, Ashish ^{[2
]}

Eckert, Laurent ^{[3
]}

Rosner, Karli ^{[4
]}

机构：

[1] George Washington Univ, Sch Med, Washington, DC 20052 USA

[2] Regeneron Pharmaceut, Tarrytown, NY USA

[3] Sanofi, Paris, France

[4] Sanofi Genzyme, Cambridge, MA USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2020年 / 83卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

15013

引用

页码：AB26 / AB26

页数：1

共 50 条

[21] CORRELATIONS OF ITCH WITH QUALITY OF LIFE AND SIGNS OF ATOPIC DERMATITIS ACROSS DUPILUMAB TRIALS
Yosipovitch, G.
Eckert, L.
Chen, Z.
Ardeleanu, M.
Shumel, B.
Plaum, S.
Graham, N.
Pirozzi, G.
Gadkari, A.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S95 - S95
[22] Dupilumab Efficacy and Safety in Adolescents with Moderate-to-Severe Atopic Dermatitis: A Case Series
Mareschal, Adrien
Puzenat, Eve
Aubin, Francois
ACTA DERMATO-VENEREOLOGICA, 2020, 100 (01)
[23] Dupilumab improves signs and symptoms of severe atopic dermatitis in children aged 6-11 years with and without comorbid asthma
Prescilla, R.
Bieber, T.
Boguniewicz, M.
Siegfried, E. C.
Chen, Z.
Shumel, B.
ALLERGY, 2021, 76 : 229 - 229
[24] Dupilumab Improves Signs And Symptoms Of Severe Atopic Dermatitis In Children Aged 6-11 Years With And Without Comorbid Asthma
Boguniewicz, Mark
Sher, Lawrence
Paller, Amy
Siegfried, Elaine
Chen, Zhen
Prescilla, Randy
Shumel, Brad
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB32 - AB32
[25] Lebrikizumab Improves Quality of Life and Patient-Reported Symptoms of Anxiety and Depression in Patients with Moderate-to-Severe Atopic Dermatitis
Lio, Peter A.
Armstrong, April
Gutermuth, Jan
Nosbaum, Audrey
Sofen, Howard
Gil, Esther Garcia
Casillas, Marta
Chen, Sherry
Sun, Luna
Pierce, Evangeline
Elmaraghy, Hany
Dawson, Zach
Torres, Tiago
DERMATOLOGY AND THERAPY, 2024, 14 (07) : 1929 - 1943
[26] Dupilumab Improves Sleep in Adults with Moderate-to-Severe Atopic Dermatitis over 24 Weeks
Merola, Joseph F.
Chiou, Albert S.
During, Emmanuel
Foley, Peter
Ardeleanu, Marius
Wu, Jiangming
Ozturk, Zafer
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB150 - AB150
[27] Dupilumab provides long-term improvement in pruritus in children with severe atopic dermatitis and adolescents and adults with moderate-to-severe atopic dermatitis
Cork, Michael J.
Yosipovitch, Gil
Silverberg, Jonathan I.
Praestgaard, Amy
Zhang, Haixin
Wang, Zhixiao
Rossi, Ana B.
BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 : 79 - 79
[28] Dupilumab Improves Skin Lipid Barrier in Pediatric Patients With Moderate-to-Severe Atopic Dermatitis
Bronova, Irina
Berdyshev, Evgeny
Goleva, Elena
Danby, Simon
Bronoff, Anna Sofia
Richers, Brittany
Garcia, Shannon
Gama, Marco Ramirez
Taylor, Patricia
Zahn, Joseph
Agueusop, Inoncent
Bafna, Shantanu
Boguniewicz, Mark
Ong, Peck
Zhang, Annie
Cork, Michael
Leung, Donald
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB5 - AB5
[29] Dupilumab significantly improves skin barrier function in patients with moderate-to-severe atopic dermatitis
Berdyshev, Evgeny
Goleva, Elena
Bissonnette, Robert
Bronova, Irina
Bronoff, Anna Sofia
Richers, Brittany N.
Garcia, Shannon
Ramirez-Gama, Marco
Taylor, Patricia
Praestgaard, Amy
Agueusop, Inoncent
Jurvilliers, Pauline
Boguniewicz, Mark
Levit, Noah A.
Rossi, Ana B.
Zhang, Annie
Leung, Donald Y. M.
ALLERGY, 2022, 77 (11) : 3388 - 3397
[30] Dupilumab and quality of life in adults with atopic dermatitis
不详
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (03) : 479 - 479

← 1 2 3 4 5 →